Colgate-Palmolive (India) (500830) Q4 02/03 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 02/03 earnings summary
19 Oct, 2026Executive summary
FY02/03 net profit rose 27% to Rs 88.66 crore, while sales fell to Rs 1,056.89 crore amid weak demand and continued trade-inventory reduction.
Consolidated profit after tax was Rs 85.42 crore; consolidated EPS was Rs 6.28.
Financial highlights
Standalone total revenue was Rs 1,092.65 crore vs Rs 1,191.84 crore; PBT rose to Rs 146.48 crore from Rs 114.69 crore.
Standalone PAT was Rs 88.66 crore vs Rs 69.79 crore; EPS increased to Rs 6.52 from Rs 5.13.
Consolidated revenue was Rs 1,091.62 crore vs Rs 1,188.72 crore; consolidated PBT was Rs 142.68 crore vs Rs 111.35 crore.
Consolidated operating cash flow was Rs 165.74 crore vs Rs 123.36 crore; cash and cash equivalents closed at Rs 100.48 crore.
Outlook and guidance
Planned direct coverage expansion by at least 10,000 villages, supported by rural wholesale promotions and seeding initiatives.
Targeted automation of stockists contributing 65% of sales by year-end, building on online coverage of stockists in the top 50 cities.
Management expected market-development and expansion efforts to support healthy oral-care market growth over the next few years.
Latest events from Colgate-Palmolive (India)
- Q2 sales rose 12.2%, gross margin reached 69.6%, and adjusted PAT grew 5.5%.500830
Q2 26/27 - Sales grew 16.5%, but excise-related inventory costs constrained profit growth.500830
Q4 96/97 - Sales advanced amid sluggish demand as strategic investments and product launches expanded.500830
Q4 97/98 - Profit fell amid weak demand, while product launches and capacity expansion positioned growth.500830
Q4 98/99 - Sales rose 12% and adjusted profit 23% despite a depressed FMCG market.500830
Q4 99/00 - Sales and profit advanced on launches and cash generation despite weak demand.500830
Q4 00/01 - Profit rose 22% as price cuts revived toothpaste demand and capacity expansion advanced.500830
Q4 03/04 - Profit rose 12% on flat sales, despite a major depreciation charge.500830
Q4 01/02 - Sales rose 17%, record profit grew 21%, and Nepal toothpaste production ended.500830
Q4 05/06